Atrazine


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000013 Congenital Abnormalities PMID:28931070; PMID:34600026
MESH:D000015 Abnormalities, Multiple PMID:20809547
MESH:D000230 Adenocarcinoma PMID:21768606
MESH:D000303 Adrenal Cortex Diseases PMID:27102619
MESH:D000382 Agricultural Workers' Diseases PMID:11874814; PMID:15583372; PMID:17327316; PMID:18343878; PMID:20730623
MESH:D001930 Brain Injuries PMID:34994930
MESH:D001943 Breast Neoplasms PMID:21768606; PMID:28931070
MESH:D003072 Cognition Disorders PMID:23770127; PMID:31187311; PMID:34030342
MESH:D003110 Colonic Neoplasms PMID:20730623
MESH:D003456 Cryptorchidism PMID:33463082
MESH:D003920 Diabetes Mellitus PMID:18343878
MESH:D003924 Diabetes Mellitus, Type 2 PMID:31319158
MESH:D004065 Digestive System Abnormalities PMID:38369735
MESH:D004714 Endometrial Hyperplasia PMID:33781367
MESH:D005317 Fetal Growth Retardation PMID:20019915; PMID:21367690
MESH:D005327 Fetal Resorption PMID:34600026
MESH:D005832 Genital Diseases, Male PMID:34600026
MESH:D006201 Hair Diseases PMID:36282381
MESH:D006948 Hyperkinesis PMID:23123945; PMID:28931070
MESH:D006984 Hypertrophy PMID:29908168
MESH:D007021 Hypospadias PMID:33463082
MESH:D007153 Immunologic Deficiency Syndromes PMID:28267632
MESH:D007248 Infertility, Male PMID:12948887; PMID:34600026
MESH:D007674 Kidney Diseases PMID:30360616; PMID:35440735
MESH:D007676 Kidney Failure, Chronic PMID:26177651
MESH:D007859 Learning Disabilities PMID:20624442; PMID:23123945
MESH:D007889 Leiomyoma PMID:33781367
MESH:D008569 Memory Disorders PMID:30065202; PMID:30580161
MESH:D008599 Menstruation Disturbances PMID:15583372
MESH:D008654 Mesothelioma PMID:1916698
MESH:D009069 Movement Disorders PMID:23770127
MESH:D009135 Muscular Diseases PMID:24863870
MESH:D009369 Neoplasms PMID:35440735
MESH:D009410 Nerve Degeneration PMID:26075868; PMID:30084861; PMID:34624533; PMID:34994930
MESH:D009765 Obesity PMID:35440735
MESH:D009845 Oligospermia PMID:22372587; PMID:22897171; PMID:34600026
MESH:D010300 Parkinson Disease PMID:17218051
MESH:D010302 Parkinson Disease, Secondary PMID:31185338
MESH:D011041 Poisoning PMID:20331876
MESH:D011248 Pregnancy Complications PMID:21367690
MESH:D011297 Prenatal Exposure Delayed Effects PMID:20624442; PMID:28931070; PMID:31187311; PMID:31755359; PMID:36831314
MESH:D011469 Prostatic Diseases PMID:35440735
MESH:D011628 Puberty, Delayed PMID:23197165; PMID:35440735
MESH:D011629 Puberty, Precocious PMID:28931070
MESH:D012135 Respiratory Sounds PMID:11874814; PMID:27384423
MESH:D012466 Salivary Gland Diseases PMID:34994930
MESH:D012734 Disorders of Sex Development PMID:20368127; PMID:34600026
MESH:D013217 Starvation PMID:28542405
MESH:D013733 Testicular Diseases PMID:28931070; PMID:33766575; PMID:35440735
MESH:D015430 Weight Gain PMID:34600026
MESH:D015431 Weight Loss PMID:23376530; PMID:24632104; PMID:24863870; PMID:30084861; PMID:33485040; PMID:33715114; PMID:35440735; PMID:36282381; PMID:38056589
MESH:D016640 Diabetes, Gestational PMID:17327316
MESH:D018226 Fibroadenoma PMID:21768606
MESH:D018476 Hypokinesia PMID:23123945
MESH:D018908 Muscle Weakness PMID:34624533
MESH:D019957 Motor Skills Disorders PMID:23123945
MESH:D020258 Neurotoxicity Syndromes PMID:31187311; PMID:36216167
MESH:D020567 Fetal Weight PMID:34600026
MESH:D048629 Micronuclei, Chromosome-Defective PMID:22153302
MESH:D052439 Lipid Metabolism Disorders PMID:38056589
MESH:D053627 Asthenozoospermia PMID:22897171
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:26476475; PMID:33485040; PMID:36282381
MESH:D064420 Drug-Related Side Effects and Adverse Reactions PMID:24211793
MESH:D064806 Dysbiosis PMID:33485040
MESH:D065631 Rhinitis, Allergic PMID:27384423
MESH:D066088 Infant Death PMID:28542405
MESH:D066126 Cardiotoxicity PMID:27112537

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.